Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:36:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The updates include adding a 'Locations' and 'Texas' label and removing the 'Texas Locations' header, and removing the HHS Vulnerability Disclosure footer link. These are minor labeling and navigation changes that do not affect study data, eligibility, or user actions.
    Difference
    0.2%
    Check dated 2025-12-23T13:51:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision notice updated from v3.3.1 to v3.3.2 across the page footer, indicating a minor site update that does not affect study content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:51:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new note clarifying that publications are automatically filled from PubMed and may not be about the study was added, and the footer revision label changed from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T15:07:37.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The site-wide funding-status notice was removed; no core study information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:37:58.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Updated the Study Details page to include results-related sections and new timing information. Dates for enrollment, primary completion, and study completion have been updated.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:49.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.